Keloids and hypertrophic scars are abnormalities in the normal wound healing characterized by greater and more sustained extracellular matrix deposition that develops after any insult in the dermis.

It can affect the patient's quality of life, both physically and psychologically.

Hypertrophic scars are raised fibrous tissue scars that remains within the boundaries of the wound. Hypertrophic scars that resulted from surgery or trauma are called linear hypertrophic scars while those from burn injuries or extensive tissue trauma and/or infections are called widespread hypertrophic scars.

Keloids are elevated fibrous scars that extend beyond the borders of the original wound. Major keloids resulted from minor trauma while for those from genetic predisposition with autosomal-predominant features are called minor keloids.




  • Post-excisional electron beam irradiation or brachytherapy (using Iridium-192) are alternative treatment options for adult patients w/ keloids or hypertrophic scars at high risk for recurrence
  • Inhibits new cell proliferation by mitosis-induced cell death or altering mitosis; also possesses antiinflammatory effects by inducing lymphocyte apoptosis, fibroblast differentiation, leukocyte & oligonucleotide adhesion
  • Should be done w/ proper coordination w/ an experienced radiation oncologist to decrease risk of unwanted adverse events (eg hyperpigmentation, atrophy, carcinogenesis)
Editor's Recommendations
Most Read Articles
25 Apr 2019
A recent study has demonstrated the potential of clindamycin as a treatment alternative to antibiotic combination regardless of hidradenitis suppurativa (HS) clinical stage.
28 Apr 2019
Women who adopt healthy diets appear to have less severe facial wrinkles, according to a new Dutch study.
01 May 2019
New drug applications approved by US FDA as of 16 - 30 April 2019 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.